Small Business Resources, Business Advice and Forms from AllBusiness.com

EVOTEC OAI/PANACOS TO DEVELOP ANTI-HIV THERAPIES.

Evotec OAI AG (Deutsche Borse: EVT, TecDAX 30), a partner for integrated high-value-added drug discovery and development solutions to the pharmaceutical and biotechnology industries, and Panacos Pharmaceuticals, Inc., a biotechnology company developing novel antiviral drugs for the treatment of Human Immunodeficiency Virus (HIV) infection and other major viral diseases, have entered into a medicinal chemistry collaboration.

Panacos will take advantage of Evotec OAI's full range of state-of-the-art medicinal chemistry capabilities to identify drug candidates for the tre

In addition, make sure to read these premium articles also available with your free trial:

T T T
art_print Printart_email Email 16x16-digg-guy  Digg It delicious-small  del.icio.us

Related Resources

Free AllBusiness Articles

  • Panacos to Present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference.
    • WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference to be held from April 11-12, 2007 at the Millennium Broadway hotel in New York, NY. Alan W....
  • Panacos Secures $20 Million Debt Financing.
    • WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ:PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, announced that it has closed a $20 million term loan agreement today with Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC). Under the terms of the loan agreement, Hercules has advanced ......
  • Vertex secures hepatitis C license agreement.
    • Vertex Pharmaceuticals, Inc. (Cambridge, MA) has entered into a nonexclusive licensing agreement with Chiron Corporation (Emeryville, CA) granting Vertex a license to discover, develop and commercialize small molecule therapeutic agents against certain hepatitis C drug targets. The financial terms and other details of the license were not disclosed. "Vertex has ......
  • Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China.
    • BOCA RATON, Fla. -- Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has today announced that its drug discovery division, ReceptoPharm, has successfully completed initial discussions with Zhong Xin Dong Tai Co., Ltd. (Nanogene Biotechnology) to develop RPI-MN for the Chinese market....
  • The Long March of Drug Discovery
    • NEW DRUGS can take years to research and cost billions of dollars to develop. For this reason, New Jersey's pharmaceutical companies invest significant amounts of money into research and development (R&D) each year.
  • Panacos Announces Bevirimat Phase 2b Dose Escalation Strategy.
    • Next Cohort to Receive 250 mg Oral Solution Dose WATERTOWN, Mass. -- Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, today announced that the Company and the US Food and Drug Administration (FDA) have agreed to a revised trial design ......
  • Virologic receives patent for hepatitis B drug resistance testing.
    • ViroLogic, Inc. (S. San Francisco, CA; 650-624-4164) announced the issuance of 42 separate claims in United States Patent 6,242,187 related to hepatitis B virus (HBV) drug resistance testing. The additional issued claims, which are assigned exclusively to ViroLogic, relate to anti-HBV drug susceptibility testing in various settings, including patient treatment, ......
Related Topics
Tools

Sponsored Links

Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Email Marketing Lists | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.